Where to Inject Tirzepatide: Abdomen, Thigh, or Upper Arm

October 7, 2025

Last Updated: Oct 07, 2025

Weight Loss
10 min read

Learn safe injection sites and how to rotate them for medications containing tirzepatide (abdomen, thigh, or upper arm). Plus rotation, technique, and storage tips.

Key takeaways
  • Three injection sites: abdomen, thigh, and upper arm are approved sites. Per FDA-approved product labels, medications containing tirzepatide may be injected subcutaneously into the abdomen, thigh, or (by another person) the back of the upper arm.
  • Upper arm: Have another person inject the back of your arm. This area is difficult to reach properly.
  • Rotate weekly: Rotate sites with each weekly dose to reduce irritation and support consistent absorption.
  • Technique matters: Pinch, 90° angle, deliver full dose, hold ~10 seconds, and dispose in a sharps container.
  • Storage: Follow your product’s instructions for use; typically refrigerate 36–46°F (2–8°C); you may store a pen at room temp up to 86°F (30°C) for up to 21 days; do not freeze.

Important notice on compounded medications: Compounded medications are not FDA-approved and may be prescribed only when a licensed prescriber determines a clinically significant difference for an identified patient. These medications are not reviewed by the FDA for safety, efficacy, or quality. Eden coordinates care; licensed providers evaluate and prescribe; partner pharmacies dispense and label.

In this guide, we’ll walk through the basics of properly injecting tirzepatide, covering common subcutaneous sites, rotation, timing, and safe handling. Per FDA-approved labeling for Mounjaro® and Zepbound®, inject tirzepatide subcutaneously into the abdomen, thigh, or have another person inject the back of your upper arm. Each location offers practical advantages for safe medication delivery and weekly self-care.

Are Compounded GLP‑1+GIP right for you?

Is Compounded GLP‑1+GIP right for you?

Is Compounded GLP‑1+GIP right for you?

Get started

Where to Inject Tirzepatide

Inject into the fatty layer just beneath the skin, not into muscle like many vaccines. The sections below explain site selection, technique, and rotation.

Upper Arm

Use the fleshy area on the back of the upper arm in the triceps region. Have another person inject this area and avoid muscle. 

Placement tips (upper arm):

  • Avoid the inner arm
  • Never inject into a vein or muscle

Abdomen

The abdomen is generally the most popular injection site for tirzepatide. Place your injection at least two inches away from your navel.

Tip: Use the large surface area to rotate spots and avoid irritated or scarred skin.

Thigh

Your thigh is another excellent option. Target the front or outer portions of your thighs where there’s enough fatty tissue.

Some patients experience discomfort with thigh injections. Choose a fleshy area free of scars or bruises and keep rotating locations over time.

Rotate injection sites

You should alternate between injection sites weekly to prevent skin irritation, reduce the risk of infection, avoid the development of fatty lumps, and help maintain consistent absorption.

{{primary-cta}}

How to Inject 

Gather supplies: your tirzepatide pen (or vial/syringe if prescribed), alcohol swabs, clean gauze/cotton, and a sharps container.

Clean: Wash hands with soap and warm water. Check the solution (clear to slightly yellow, with no particles) and verify the expiration date.

Prep the skin: Clean with an alcohol swab and allow to air-dry completely. Do not touch or blow on the site.

Steps (follow your device's instructions for use):

  • Pinch the skin to lift the fatty layer
  • Place the pen/syringe at a 90° angle (unless your device instructions for use say otherwise)
  • Press the injection button or depress the plunger fully
  • Hold steady for about 10 seconds
  • Confirm full dose per your device (clicks/window/plunger)

Do not throw loose needles, syringes, or pens in household trash or recycling. Place them in an FDA-cleared sharps container and follow your local disposal rules.

Comfort tips:

  • Rotate sites weekly
  • Avoid bruised, scarred, or irritated skin
  • Let alcohol fully dry before injecting
  • Avoid rubbing the site afterward

Missed dose: Follow the missed-dose instructions in your product labeling or contact your clinician.

Rotation & Common Mistakes

Rotate consistently (a different spot within the same general area each week) to help avoid tissue changes that can affect absorption.

Avoid these mistakes:

  • Re-using the exact same spot week after week
  • Touching the needle or sterilized surfaces before injection
  • Injecting into muscle instead of fatty tissue
  • Discarding sharps in regular trash
  • Irregular or missed doses

Do not adjust your dose without medical guidance. Incorrect dosing can cause serious side effects (e.g., severe nausea/vomiting, hypoglycemia, etc.).

Pro tip: Keep a simple log of dates and locations to make rotation effortless.

{{primary-cta}}

When to Contact a Clinician

Tirzepatide may cause side effects, most commonly gastrointestinal symptoms (nausea, vomiting, diarrhea, decreased appetite), with rarer but serious risks discussed below; review these with your provider.

Call emergency services immediately for:

  • Signs of severe allergic reaction (trouble breathing, dizziness, facial swelling, throat tightness)
  • Possible pancreatitis (severe upper stomach pain radiating to the back with nausea/vomiting)

Call your healthcare provider promptly for:

  • Persistent/severe stomach problems
  • Vision changes or blurred vision
  • Possible thyroid tumor signs (neck lump/swelling, hoarseness, trouble swallowing, shortness of breath)
  • Possible gallbladder issues (upper stomach pain, yellowing skin/eyes, pale/chalky stools, nausea, bloating)
  • Low blood sugar symptoms (headache, hunger, weakness, sweating, confusion, dizziness, fast heartbeat)
  • Kidney problems (decreased urination, swelling in feet/ankles/hands)
  • Mental health changes (agitation, depression, suicidal thoughts)

For dosing concerns or a potential overdose, contact your healthcare provider or Poison Control (1-800-222-1222).

Storage & Travel

Your tirzepatide needs proper storage to maintain its effectiveness. Unused pens or vials require refrigeration between 36°F-46°F (2°C-8°C) until the printed expiration date. Keep the medication in its original carton to protect it from light.

Storage (follow your product’s label/Instructions for use):

  • Refrigerate at 36–46°F (2–8°C); protect from light; do not freeze
  • A pen may be kept at room temperature up to 86°F (30°C) for up to 21 days (check your specific product’s instructions)
  • Do not use if frozen, discolored, or with particles

Travel tips:

  • Carry-on only; avoid temperature extremes in checked bags
  • Use an appropriate cooling case if needed (never place pens directly on ice)
  • Keep medication in original packaging with labels visible
  • Carry your prescription and any needed travel documentation
  • Never leave tirzepatide in a car (heat/cold can exceed safe limits)

Important Notes on Compounded vs. FDA-Approved Products

Understanding the differences between FDA-approved tirzepatide and compounded versions is important for your treatment safety. FDA-approved tirzepatide products (Mounjaro®, Zepbound®) have been reviewed for safety, effectiveness, and quality. Compounded tirzepatide is not FDA-approved and may vary in formulation and potency; it may be prescribed only when clinically appropriate for an identified patient.

Conclusion

Proper tirzepatide administration comes down to choosing an appropriate site (abdomen, thigh, or, by another person, on the back of the upper arm), using proper technique, and rotating weekly. Follow your product’s Instructions for Use and your clinician’s guidance. Watch for concerning symptoms and store your medication correctly. When available and appropriate, FDA-approved products are recommended.

Curious about oral tirzepatide? Check out our blog covering oral tirzepatide availability.

Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.

Frequently asked questions

Which injection site is most effective for tirzepatide?

All label-supported sites (abdomen, thigh, and back of the upper arm) are suitable for subcutaneous tirzepatide. Rotate sites weekly. If using the upper arm, have another person give the injection.

Can tirzepatide be injected into the thigh?

Yes. Use the front or outer thigh where there is sufficient fatty tissue. It’s accessible when sitting and offers room for rotation.

Is it safe to inject tirzepatide in the abdomen?

Yes. Inject at least 2 inches (5 cm) away from the navel, and rotate sites each week.

How should I rotate tirzepatide injection sites?

Use a different spot each week within the same general area (abdomen, thigh, or upper arm). A simple log helps ensure consistent rotation.

What are the storage requirements for tirzepatide?

Refrigerate at 36–46°F (2–8°C) and protect from light. You may store a pen at room temperature up to 86°F (30°C) for up to 21 days (check your product’s instructions for use). Do not freeze.

Blog Components

Compounded GLP‑1+GIP
Personalized doctor-led plans
First month for $299*
Get started
*On a monthly plan.
Important safety information
"I had an incredible experience, and the support that Eden provides is 10/10"
Kerstin
Verified Customer
“I had so many questions in the beginning, and both the doctor and customer support were so patient and thorough.”
Lane L.
Verified Customer

Are Compounded GLP‑1+GIP right for you?

Is Compounded GLP‑1+GIP right for you?

Is Compounded GLP‑1+GIP right for you?

Get started

References

Eli Lilly and Company. (2022). HIGHLIGHTS OF PRESCRIBING INFORMATION. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf

Frías, J. P., Davies, M. J., Rosenstock, J., Manghi, F. C. P., Landó, L. F., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/nejmoa2107519

HIGHLIGHTS OF PRESCRIBING INFORMATION. (2023). [Prescribing information]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf

Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/nejmoa2206038

Lilly USA, LLC. (2023). INSTRUCTIONS FOR USE. https://pi.lilly.com/us/zepbound-pen-us-ifu.pdf

Lilly USA, LLC. (2024). INSTRUCTIONS FOR USE. https://pi.lilly.com/us/mounjaro-us-ifu.pdf

Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Eden is not affiliated with or endorsed by Eli Lilly and Company.